| 1 |
26014752 | Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel. | 2015 Oct |
2 |
| 2 |
26237513 | Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization. | 2015 |
1 |
| 3 |
26264906 | Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease. | 2015 Dec |
1 |
| 4 |
26413105 | An Assay of Measuring Platelet Reactivity Using Monoclonal Antibody against Activated Platelet Glycoprotein IIb/IIIa in Patients Taking Clopidogrel. | 2015 Sep |
1 |
| 5 |
24609741 | Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke. | 2014 Mar 8 |
1 |
| 6 |
23311679 | Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel. | 2013 Oct |
2 |
| 7 |
22448399 | Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents. | 2012 Mar 1 |
2 |
| 8 |
23363669 | [Analysis of the risk factors of patients with acute coronary syndrome suffering hemorrhage during hospitalization]. | 2012 Nov |
1 |
| 9 |
21901881 | [Resistance to antiplatelet drugs in patients with cerebrovascular disorders]. | 2011 |
1 |
| 10 |
21920970 | Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. | 2011 Dec |
1 |
| 11 |
19067731 | The genetics of antiplatelet drug resistance. | 2009 Jan |
1 |
| 12 |
18343263 | Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. | 2008 Feb |
1 |
| 13 |
18458661 | Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials. | 2008 Mar |
1 |
| 14 |
18481820 | Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention. | 2008 Mar |
1 |
| 15 |
18489507 | Using triple antiplatelet therapy in patients with non-ST elevation acute coronary syndrome managed invasively: a cost-effectiveness analysis. | 2008 Sep-Oct |
1 |
| 16 |
18687246 | The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. | 2008 Aug 12 |
2 |
| 17 |
19463379 | Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. | 2008 Dec |
1 |
| 18 |
17334935 | Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison. | 2007 Dec |
1 |
| 19 |
16421012 | Effect of combined administration of clopidogrel and lysine acetylsalicylate versus clopidogrel and aspirin on platelet aggregation and activated GPIIb/IIIa expression in healthy volunteers. | 2006 Mar |
1 |
| 20 |
16645157 | Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. | 2006 Aug |
1 |
| 21 |
17020571 | Debate of adjunctive pharmacology for percutaneous coronary intervention: anticoagulation and clopidogrel are not (always) enough. | 2006 Oct |
1 |
| 22 |
17161243 | Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. | 2006 Dec 5 |
2 |
| 23 |
15738352 | Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. | 2005 Mar 8 |
1 |
| 24 |
16149027 | Is platelet adhesion assay able to quantify drug-induced platelet dysfunction? | 2005 |
1 |
| 25 |
19758929 | Adjunctive Antiplatelet / Antithrombotic therapy in percutaneous coronary intervention. | 2005 Nov |
1 |
| 26 |
14736431 | Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study. | 2004 Jan 21 |
1 |
| 27 |
14979400 | Combination antiplatelet therapy in patients with peripheral vascular bypass grafts. | 2004 Jan |
1 |
| 28 |
15085057 | Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: Part 2: When and how to use various agents. | 2004 Apr |
1 |
| 29 |
15487851 | [Current pharmacological principles to inhibit platelet function and their clinical implications. Focus on clopidogrel]. | 2004 Aug 15 |
1 |
| 30 |
12588350 | Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP. | 2003 Feb |
1 |
| 31 |
12595840 | Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. | 2003 Feb |
1 |
| 32 |
12812377 | Management of thrombotic and cardiovascular disorders in the new millenium. | 2003 Apr |
2 |
| 33 |
14522478 | Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). | 2003 Oct 1 |
1 |
| 34 |
14618072 | Comparative pharmacology of GP IIb/IIIa antagonists. | 2003 Apr |
1 |
| 35 |
11904526 | Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation. | 2002 Apr |
1 |
| 36 |
12204495 | Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). | 2002 Aug 21 |
1 |
| 37 |
10741635 | Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A. | 2000 Mar |
5 |
| 38 |
10581998 | [Where to look for progress in antithrombotic treatments?]. | 1999 Oct 1 |
1 |
| 39 |
8977459 | Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation. | 1996 Dec |
1 |